Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit www.thehonorstudy.com or www.clinicaltrials.gov (NCT03062540).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
04/19/18 DEF 14A Definitive proxy statements 84
04/13/18 8-K Current report filing
Related Documents
166
04/03/18 8-K Current report filing
Related Documents
170
03/12/18 8-K Current report filing
Related Documents
8
03/09/18 10-K Annual report pursuant to Section 13 and 15(d) 130
03/09/18 4 Statement of changes in beneficial ownership of securities 2
03/09/18 4 Statement of changes in beneficial ownership of securities 2
03/09/18 4 Statement of changes in beneficial ownership of securities 2
03/09/18 4 Statement of changes in beneficial ownership of securities 2
03/09/18 4 Statement of changes in beneficial ownership of securities 2